U.S. stock market anomaly | BrainGenius Technology (RGC.US) has risen more than 47% and has gained over 6246% since the beginning of the year.

According to the Wise Financial APP, on Friday, the stock price of ReNeuron Group plc (RGC.US) soared, with the stock rising over 47% to $313.54 at the time of publication. The stock has risen over 6246% since the beginning of the year. ReNeuron Group plc is an early-stage biotechnology company focused on the research and commercialization of traditional Chinese medicine for the treatment of neurocognitive disorders and degenerative diseases, particularly ADHD and ASD.